Literature DB >> 20422788

Can primary immunodeficiencies help to provide insights into infectious risks of therapeutic antibodies?

László Maródi1, Jean-Laurent Casanova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20422788     DOI： 10.1038/nri2764

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  22 in total

1.  Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections.

Authors:  Smita Y Patel; Li Ding; Margaret R Brown; Larry Lantz; Ted Gay; Stuart Cohen; Lenna A Martyak; Bernard Kubak; Steven M Holland
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

2.  Enteroviral meningoencephalitis after anti-CD20 (rituximab) treatment.

Authors:  Pierre Quartier; Olivier Tournilhac; Christine Archimbaud; Leila Lazaro; Carine Chaleteix; Pascale Millet; Hélène Peigue-Lafeuille; Stéphane Blanche; Alain Fischer; Jean-Laurent Casanova; Philippe Travade; Marc Tardieu
Journal:  Clin Infect Dis       Date:  2003-01-16       Impact factor: 9.079

Review 3.  The late adverse events of rituximab therapy--rare but there!

Authors:  Ron Ram; Isaac Ben-Bassat; Ofer Shpilberg; Aaron Polliack; Pia Raanani
Journal:  Leuk Lymphoma       Date:  2009-07

4.  Biologic agents for the treatment of juvenile rheumatoid arthritis: current status.

Authors:  Ruy Carrasco; Judith A Smith; Daniel Lovell
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

Review 5.  Infectious complications of rituximab in patients with lymphoma during maintenance therapy: a systematic review and meta-analysis.

Authors:  Sercan Aksoy; Omer Dizdar; Mutlu Hayran; Hakan Harputluoğlu
Journal:  Leuk Lymphoma       Date:  2009-03

Review 6.  Infectious complications of biologic agents.

Authors:  Emilio Martin-Mola; Alejandro Balsa
Journal:  Rheum Dis Clin North Am       Date:  2009-02       Impact factor: 2.670

Review 7.  Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.

Authors:  Shen-Ying Zhang; Stéphanie Boisson-Dupuis; Ariane Chapgier; Kun Yang; Jacinta Bustamante; Anne Puel; Capucine Picard; Laurent Abel; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

Review 8.  Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases.

Authors:  Jacinta Bustamante; Stéphanie Boisson-Dupuis; Emmanuelle Jouanguy; Capucine Picard; Anne Puel; Laurent Abel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2008-02       Impact factor: 7.486

9.  Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.

Authors:  Takuji Suzuki; Takuro Sakagami; Bruce K Rubin; Lawrence M Nogee; Robert E Wood; Sarah L Zimmerman; Teresa Smolarek; Megan K Dishop; Susan E Wert; Jeffrey A Whitsett; Gregory Grabowski; Brenna C Carey; Carrie Stevens; Johannes C M van der Loo; Bruce C Trapnell
Journal:  J Exp Med       Date:  2008-10-27       Impact factor: 14.307

10.  Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1.

Authors:  Margarita Martinez-Moczygemba; Minh L Doan; Okan Elidemir; Leland L Fan; Sau Wai Cheung; Jonathan T Lei; James P Moore; Ghamartaj Tavana; Lora R Lewis; Yiming Zhu; Donna M Muzny; Richard A Gibbs; David P Huston
Journal:  J Exp Med       Date:  2008-10-27       Impact factor: 14.307
View more
  4 in total

Review 1.  To Extinguish the Fire from Outside the Cell or to Shutdown the Gas Valve Inside? Novel Trends in Anti-Inflammatory Therapies.

Authors:  Annalisa Marcuzzi; Elisa Piscianz; Erica Valencic; Lorenzo Monasta; Liza Vecchi Brumatti; Alberto Tommasini
Journal:  Int J Mol Sci       Date:  2015-09-07       Impact factor: 5.923

2.  Autoimmunity as a predisposition for infectious diseases.

Authors:  Mohan S Maddur; Janakiraman Vani; Sébastien Lacroix-Desmazes; Srinivas Kaveri; Jagadeesh Bayry
Journal:  PLoS Pathog       Date:  2010-11-04       Impact factor: 6.823

3.  [Medicinal prophylaxis during intensified immunosuppression in children and adolescents : part 2].

Authors:  F Speth; N Wellinghausen; J-P Haas
Journal:  Z Rheumatol       Date:  2013-11       Impact factor: 1.372

4.  Immunological Changes in Blood of Newborns Exposed to Anti-TNF-α during Pregnancy.

Authors:  Ana Esteve-Solé; Àngela Deyà-Martínez; Irene Teixidó; Elena Ricart; Macarena Gompertz; Maria Torradeflot; Noemí de Moner; Europa Azucena Gonzalez; Ana Maria Plaza-Martin; Jordi Yagüe; Manel Juan; Laia Alsina
Journal:  Front Immunol       Date:  2017-09-21       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.